PRCT Q4 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$68M+56.6% YoY

Gross Profit

$44M64.0% margin

Operating Income

-$20M-28.9% margin

Net Income

-$19M-27.6% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+16.9%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$34M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$534M

Total Liabilities

$132M

Stockholders' Equity

$402M

Cash & Equivalents

$334M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$44M	+56.6%
Gross Profit	$44M	$21M	+105.5%
Operating Income	-$20M	-$30M	+33.3%
Net Income	-$19M	-$28M	+31.4%

Geographic Segments

UNITED STATES

$60M88%

Outside the United States

$8M12%